Exclusive

Publication

Byline

Are you a "Dimagi Naxal?"

India, Aug. 24 -- The politics of labelling certain groups or ideologies to demarcate them is emerging day by day from responsible individuals to particular groups. The most recent example is the expr... Read More


Dimaagi Naxals, Manufacturing a New Enemy

India, Aug. 24 -- Prime Minister Narendra Modi is known for coining new political terminologies, particularly for his opponents and critics. These include Andolanjeevi for protesters; Urban Naxals for... Read More


Inventing the Enemy

India, Aug. 24 -- The politics of labelling is not uniquely Indian. Across time and space, governments and political movements have employed the tactic of naming their opponents that carry an immediat... Read More


CheQ Moves From Credit Management To Everyday UPI Payments

New Delhi, Aug. 24 -- CheQ has launched CheQ UPI. The Bengaluru-based credit card management platform said the service will allow users to make UPI payments through linked bank accounts and RuPay cred... Read More


Realme P4s launches August 26 with an 8,000mAh battery but will price decide its fate?

India, Aug. 24 -- Realme is officially adding another performance-focused P-series smartphone to its lineup in India with the Realme P4s 5G. The company has announced that the smartphone will launch i... Read More


TVS Supply Chain Solutions, Japan's Sankyu Inc. Ink Strategic MoU

Mumbai, Aug. 24 -- TVS Supply Chain Solutions has signed a Memorandum of Understanding with Japan-based Sankyu Inc. to collaborate across supply chain and engineering services. As part of the agreeme... Read More


GC Biopharma's Hunter Syndrome treatment 'Hunterase' receives drug approval in India and Taiwan

Singapore, Aug. 24 -- GC Biopharma, a leading global pharmaceutical company based in South Korea, has announced that its Hunter syndrome treatment, 'Hunterase IV', has received marketing authorisation... Read More


Hong Kong Applied Science and Technology Research Institute advances AI-enabled biomaterials and digital health innovation

Singapore, Aug. 24 -- The Hong Kong Applied Science and Technology Research Institute (ASTRI) and Saint Francis University (SFU), US have signed a Memorandum of Understanding (MoU) to establish a stra... Read More


Korea's Rznomics joins Lilly Gateway Labs in US to accelerate RNA Therapeutics

Singapore, Aug. 24 -- South Korea based Rznomics Inc, a biopharmaceutical company specialising in the development of RNA-based gene therapies, has announced that it is joining Lilly Gateway Labs (LGL)... Read More


Charles River Laboratories collaborates with Taiwan's Medigen Vaccine Biologics Corp

Singapore, Aug. 24 -- US-based Charles River Laboratories International, and Medigen Vaccine Biologics Corp. (MVC), headquartered in Taiwan, have collaborated on the characterisation and validation of... Read More